Protalix BioTherapeutics Inc (FRA:PBDA)
€ 1.0515 -0.061 (-5.48%) Market Cap: 78.30 Mil Enterprise Value: 57.94 Mil PE Ratio: 116.00 PB Ratio: 2.84 GF Score: 34/100

Protalix BioTherapeutics Inc (FRA:PBDA) Transcripts

  • 1